Drug Candidates

2 candidates mapped to SDH-deficient disease pathways

All (15)established (4)clinical trial (2)preclinical (6)theoretical (3)
Temozolomide

Temodar, Temodal

clinical trial

Alkylating agent

Epigenetic Dysregulation
Evidence Score
68
FDA Approved
Telaglenastat

CB-839

clinical trial

Glutaminase inhibitor

Glutamine Dependency
Evidence Score
60